Cooper Companies | COO - Sales Revenues

Stock Price
64.42
Daily Change
-0.53 -0.82%
Monthly
-9.84%
Yearly
-20.36%
Q2 Forecast
63.04

Cooper Companies reported $1.02B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Abbott USD 11.16B 300M Mar/2026
Align Technology USD 1.05B 54.3M Dec/2025
AtriCure USD 140.5M 6.2M Dec/2025
Avanos Medical USD 180.9M 3.1M Dec/2025
Bausch Health Companies USD 2.8B 120M Dec/2025
Baxter International USD 2.97B 130M Dec/2025
Bayer EUR 11.44B 1.78B Dec/2025
Becton, Dickinson and Co. USD 5.3B 600M Dec/2025
Boston Scientific USD 5.2B 90M Mar/2026
Cooper Companies USD 1.02B 41.1M Dec/2025
Dentsply International USD 961M 57M Dec/2025
Dexcom USD 1.26B 50M Dec/2025
Edwards Lifesciences USD 1.65B 80M Mar/2026
Globus Medical USD 826.4M 57.4M Dec/2025
Haemonetics USD 338.97M 11.97M Dec/2025
Inogen USD 74.93M 504K Sep/2024
Insulet USD 783.8M 77.5M Dec/2025
Integra LifeSciences USD 434.9M 32.84M Dec/2025
Intuitive Surgical USD 2.77B 100M Mar/2026
J&J USD 24.1B 500M Mar/2026
Medtronic USD 9B 39M Jan/2026
Merit Medical Systems USD 393.9M 9.7M Dec/2025
Novartis USD 13.86B 498M Dec/2025
ResMed USD 1.4B 100M Dec/2025
STAAR Surgical USD 239.4M 144.7M Dec/2025
Steris USD 1.5B 470M Dec/2025
Stryker USD 7.2B 1.14B Dec/2025
Tandem Diabetes Care USD 290.4M 41.15M Dec/2025
Teleflex USD 568.98M 344.02M Dec/2025
Utah Medical Products USD 9.04M 955K Dec/2025
Zimmer Biomet Holdings USD 2.24B 240M Dec/2025